# PET CT With HX4 in Cervix Cancer

> **NCT02233387** · PHASE2 · TERMINATED · sponsor: **Maastricht Radiation Oncology** · enrollment: 4 (actual)

## Conditions studied

- Cervix Cancer

## Interventions

- **OTHER:** injection with [18F] HX4 and PET imaging

## Key facts

- **NCT ID:** NCT02233387
- **Lead sponsor:** Maastricht Radiation Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-11
- **Primary completion:** 2018-05
- **Final completion:** 2018-05
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** patients did not want to participate
- **Last updated:** 2019-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02233387

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02233387, "PET CT With HX4 in Cervix Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02233387. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*